Trading Options with an Edge
Select Page

ORMP

Search by
TICKER SYMBOL

Oramed Pharmaceuticals, Inc

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing

19.48

-1.02

(-4.976%)

Volume:

409,369

52 week range:

2.4 - 23.57

Market Cap:

633.376M

Company Description:

Oramed Pharmaceuticals is a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, with offices in the United States and Israel, Oramed has developed a novel Protein Oral Delivery (POD™) technology. Oramed is seeking to revolutionize the treatment of diabetes through its proprietary lead candidate, ORMD-0801, which has the potential to be the first commercial oral insulin capsulefor the treatment of diabetes. The Company has completed multiple Phase II clinical trials under an Investigational New Drug application with the U.S. Food and Drug Administration. In addition, Oramed is developing an oral GLP-1 (Glucagon-like peptide-1) analog capsule, ORMD-0901.